…
Fortive Corporation designs, develops, manufactures, and markets products, software, and services in the United States, China, and internationally. It operates through Intelligent Operating Solutions and Advanced Healthcare Solutions segments. The Intelligent Operating Solutions segment provides advanced instrumentation, software, and services, including maintenance, repair, measurement and condition monitoring, facility and asset lifecycle software applications, and connected worker safety and compliance solutions for manufacturing, process industries, healthcare, utilities and power, communications and electronics, and other industries. This segment markets its products and services under the ACCRUENT, FLUKE, GORDIAN, INDUSTRIAL SCIENTIFIC, INTELEX, and SERVICECHANNEL brand names. The Advanced Healthcare Solutions segment provides critical workflow solutions comprising instrument sterilization, instrument tracking, biomedical test tools, radiation detection and safety monitoring, and end-to-end clinical productivity software and solutions under the ASP, CENSIS, FLUKE BIOMEDICAL, LANDAUER, and PROVATION brand names. Fortive Corporation was incorporated in 2015 and is headquartered in Everett, Washington.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Fortive is an industrial technology company operating a diversified portfolio of instrumentation, sensing and software-enabled service businesses serving manufacturing, healthcare and transportation customers. Long-term growth drivers include recurring service and software revenue, aftermarket and automation demand and disciplined acquisitions through its operating system, which could support margin improvement and steady cash flow and may appeal to investors seeking diversified industrial exposure.
Key risks include cyclicality in industrial end markets, execution and integration risk from acquisitions, supply-chain and inflationary pressures, and sensitivity to interest rates and currency movements.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | 753.90M | 969.60M | 990.80M | 873.50M | 677.50M |
| Net income | 579.20M | 832.90M | 865.80M | 755.20M | 608.40M |
| Selling general administrative | 1661.70M | 2173.50M | 2025.00M | 1956.60M | 1839.50M |
| Gross profit | 3134.70M | 3731.00M | 3594.10M | 3363.40M | 3007.10M |
| Reconciled depreciation | 437.60M | 543.90M | 457.70M | 465.60M | 395.50M |
| Ebit | 874.40M | 1122.40M | 1133.70M | 987.40M | 812.80M |
| Ebitda | 1200.40M | 1666.30M | 1133.70M | 1455.30M | 1226.30M |
| Depreciation and amortization | 326.00M | 543.90M | 456.80M | 467.90M | 413.50M |
| Non operating income net other | - | - | - | - | -119.00M |
| Operating income | 908.90M | 1176.70M | 1133.70M | 987.40M | 812.80M |
| Other operating expenses | 4233.70M | 5055.10M | 2460.40M | 4820.40M | 4441.90M |
| Interest expense | 120.50M | 152.80M | 123.50M | 98.30M | 103.20M |
| Tax provision | 69.50M | 136.70M | 142.50M | 118.30M | 63.30M |
| Interest income | 120.50M | 192.20M | 123.50M | 98.30M | 103.20M |
| Net interest income | -120.50M | -152.80M | -127.10M | -98.30M | -103.20M |
| Extraordinary items | 46.50M | 350.40M | 0.00M | 0.00M | -5.80M |
| Non recurring | - | - | - | - | -29.90M |
| Income tax expense | 112.70M | 136.70M | 125.00M | 118.30M | 63.30M |
| Total revenue | 5142.60M | 6231.80M | 6065.30M | 5825.70M | 5254.70M |
| Total operating expenses | 2225.80M | 2554.30M | 2460.40M | 2358.10M | 2194.30M |
| Cost of revenue | 2007.90M | 2500.80M | 2472.40M | 2462.30M | 2247.60M |
| Total other income expense net | -155.00M | -207.10M | -142.90M | -113.90M | -135.30M |
| Discontinued operations | - | - | - | - | -5.80M |
| Net income from continuing ops | 532.70M | 832.90M | 827.80M | 755.20M | 614.20M |
| Net income applicable to common shares | 579.20M | 832.90M | 865.80M | 755.20M | 573.90M |
| Preferred stock and other adjustments | - | - | - | - | 34.50M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 11737.70M | 17016.10M | 16911.80M | 15890.60M | 16465.50M |
| Intangible assets | 2188.40M | 3340.00M | 3159.80M | 3487.40M | 3890.20M |
| Other current assets | 254.80M | 288.80M | 285.10M | 272.60M | 252.70M |
| Total liab | 5276.60M | 6820.50M | 6586.50M | 6202.00M | 6948.50M |
| Total stockholder equity | 6453.40M | 10188.60M | 10318.90M | 9683.40M | 9512.20M |
| Other current liab | 910.70M | 449.00M | 470.70M | 594.80M | 503.10M |
| Common stock | 3.70M | 3.70M | 3.60M | 3.60M | 3.60M |
| Capital stock | 3.70M | 3.70M | 3.60M | 3.60M | 3.60M |
| Retained earnings | 5428.50M | 8227.60M | 7505.90M | 6742.10M | 6023.60M |
| Other liab | - | - | - | 1092.30M | 1286.40M |
| Good will | 7298.30M | 10156.00M | 9121.70M | 9048.50M | 9152.00M |
| Other assets | 375.50M | 494.70M | 0.00M | 455.80M | 337.30M |
| Cash | 375.50M | 813.30M | 1888.80M | 709.20M | 819.30M |
| Cash and equivalents | 375.50M | 813.30M | 1888.80M | 709.20M | 819.30M |
| Total current liabilities | 2246.60M | 2238.40M | 1791.30M | 2727.10M | 3714.90M |
| Current deferred revenue | - | 553.20M | 544.60M | 509.60M | 457.60M |
| Net debt | 2830.50M | 3063.60M | 1921.30M | 2542.10M | 3324.20M |
| Short term debt | 899.50M | 413.00M | 37.60M | 999.70M | 2196.30M |
| Short long term debt | 899.50M | 376.20M | - | 999.70M | 2151.70M |
| Short long term debt total | 3206.00M | 3876.90M | 3810.10M | 3251.30M | 4143.50M |
| Other stockholder equity | 980.20M | 2422.70M | 3135.50M | 3263.40M | 3670.00M |
| Property plant equipment | 269.80M | 433.10M | 439.80M | 421.90M | 571.10M |
| Total current assets | 1605.70M | 2592.30M | 3671.60M | 2477.00M | 2514.90M |
| Net tangible assets | - | - | - | -2852.50M | -3530.00M |
| Short term investments | - | - | - | - | 0.00M |
| Net receivables | 683.60M | 945.40M | 960.80M | 958.50M | 930.20M |
| Long term debt | 2306.50M | 3331.10M | 3646.20M | 2251.60M | 1807.30M |
| Inventory | 291.80M | 544.80M | 536.90M | 536.70M | 512.70M |
| Accounts payable | 436.40M | 677.40M | 608.60M | 623.00M | 557.90M |
| Noncontrolling interest in consolidated entity | - | - | - | - | 4.80M |
| Accumulated other comprehensive income | 41.00M | -465.40M | -326.10M | -325.70M | -185.00M |
| Common stock total equity | - | - | - | - | 3.60M |
| Retained earnings total equity | - | - | - | - | 6023.60M |
| Non currrent assets other | 375.50M | 435.70M | 518.90M | 455.80M | 337.30M |
| Non current assets total | 10132.00M | 14423.80M | 13240.20M | 13413.60M | 13950.60M |
| Capital lease obligations | 100.60M | 169.60M | 163.90M | 169.40M | 184.50M |
| Long term debt total | 2306.50M | 3331.10M | 3646.20M | 2251.60M | 1807.30M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | - | -1796.00M | -158.40M | -102.50M | -2615.60M |
| Change to liabilities | - | - | - | 19.20M | 32.40M |
| Total cashflows from investing activities | -135.40M | -1796.00M | -195.40M | -102.50M | -2615.60M |
| Net borrowings | -714.80M | 137.00M | 389.20M | -723.90M | 753.60M |
| Total cash from financing activities | -1386.60M | -792.70M | 32.30M | -1273.00M | 652.00M |
| Change to operating activities | - | - | - | 52.60M | -6.20M |
| Net income | 579.20M | 832.90M | 865.80M | 755.20M | 614.20M |
| Change in cash | -437.80M | -1075.50M | 1179.60M | -110.10M | -1005.50M |
| Begin period cash flow | 813.30M | 1888.80M | 709.20M | 819.30M | 1824.80M |
| End period cash flow | 375.50M | 813.30M | 1888.80M | 709.20M | 819.30M |
| Total cash from operating activities | 1083.20M | 1526.80M | 1353.60M | 1303.20M | 961.10M |
| Depreciation | 437.60M | 543.90M | 456.80M | 465.60M | 395.50M |
| Other cashflows from investing activities | -4.60M | 46.20M | 8.20M | -6.70M | -2565.60M |
| Dividends paid | 92.20M | 111.20M | 102.00M | -99.50M | -132.20M |
| Change to inventory | -20.00M | 8.80M | -1.70M | -40.30M | -53.60M |
| Change to account receivables | 8.70M | -4.50M | 9.80M | -52.10M | -84.10M |
| Sale purchase of stock | -1610.10M | -889.60M | -272.90M | -442.90M | - |
| Other cashflows from financing activities | 1030.50M | 71.10M | 18.00M | 1425.90M | 1395.30M |
| Change to netincome | - | - | - | 103.00M | 68.70M |
| Capital expenditures | 105.10M | 120.40M | 107.80M | 95.80M | 50.00M |
| Change receivables | - | - | - | - | -84.10M |
| Cash flows other operating | - | - | - | - | 626.90M |
| Cash and cash equivalents changes | - | - | - | - | -1002.50M |
| Change in working capital | -399.90M | 103.90M | 21.80M | -20.60M | -111.50M |
| Stock based compensation | 116.80M | 109.20M | 113.30M | 93.80M | 77.40M |
| Other non cash items | 399.40M | 1.90M | 1035.60M | 71.30M | -29.90M |
| Free cash flow | 978.10M | 1406.40M | 1245.80M | 1207.40M | 911.10M |
Sector: Technology Industry: Scientific & Technical Instruments
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| FTV Fortive Corp |
0.84 1.38% |
61.62 | 38.35 | 20.53 | 4.66 | 2.89 | 5.18 | 18.58 |
| KYCCF Keyence |
6.88 1.38% |
506.08 | 41.66 | 38.76 | 0.11 | 5.69 | 0.10 | 0.19 |
| COHR Coherent Inc |
14.29 6.45% |
235.79 | 333.78 | 46.73 | 10.24 | 7.63 | 10.78 | 62.92 |
| GRMN Garmin Ltd |
-3.58 1.22% |
289.34 | 28.91 | 24.45 | 7.01 | 5.99 | 6.72 | 22.32 |
| KEYS Keysight Technologies Inc |
10.06 3.09% |
336.10 | 42.58 | 20.00 | 8.11 | 8.16 | 8.17 | 28.06 |
Fortive Corporation designs, develops, manufactures, and markets products, software, and services in the United States, China, and internationally. It operates through Intelligent Operating Solutions and Advanced Healthcare Solutions segments. The Intelligent Operating Solutions segment provides advanced instrumentation, software, and services, including maintenance, repair, measurement and condition monitoring, facility and asset lifecycle software applications, and connected worker safety and compliance solutions for manufacturing, process industries, healthcare, utilities and power, communications and electronics, and other industries. This segment markets its products and services under the ACCRUENT, FLUKE, GORDIAN, INDUSTRIAL SCIENTIFIC, INTELEX, and SERVICECHANNEL brand names. The Advanced Healthcare Solutions segment provides critical workflow solutions comprising instrument sterilization, instrument tracking, biomedical test tools, radiation detection and safety monitoring, and end-to-end clinical productivity software and solutions under the ASP, CENSIS, FLUKE BIOMEDICAL, LANDAUER, and PROVATION brand names. Fortive Corporation was incorporated in 2015 and is headquartered in Everett, Washington.
| Name | Title | Year Born |
|---|---|---|
| Mr. James A. Lico | Pres, CEO & Director | 1966 |
| Mr. Charles E. McLaughlin | Sr. VP & CFO | 1961 |
| Ms. Barbara B. Hulit | Exec. Advisor | 1967 |
| Mr. Edward Read Simmons | Sr. VP of Strategy | 1974 |
| Mr. Olumide Soroye | Pres & CEO of Intelligent Operating Solutions Segment | 1972 |
| Mr. Christopher M. Mulhall | VP & Chief Accounting Officer | 1973 |
| Mr. Victor P. Fetter III | Chief Information Officer | 1969 |
| Griffin Whitney | VP of Investor Relations | NA |
| Mr. Peter C. Underwood | Sr. VP & Gen. Counsel | 1970 |
| Mr. Jonathan L. Schwarz | Sr. VP of Corp. Devel. | 1972 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.